Johanna A. Kremer Hovinga Strebel, MD1, Javier de la Rubia, MD2*, Katerina Pavenski, MD, FRCPC3, Ara Metjian, MD4, Paul Knoebl, MD5*, Flora Peyvandi, MD6,7, Spero Cataland, MD8, PAUL Coppo9*, Umer Khan, MS10*, Laurel A. Menapace, MD11, Ana Paula Marques, MD12*, Sriya Gunawardena, MD13* and Marie Scully, MD14
1Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland
2Hematology Department, University Hospital La Fe, Valencia, Spain
3Departments of Medicine and Laboratory Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Canada
4University of Colorado Anschutz Medical Campus, Aurora, CO
5Division of Hematology and Hemostasis, Department of Medicine 1, Medical University of Vienna, Vienna, Austria
6Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
7Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
8Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
9Department of Hematology, Reference Center for Thrombotic Microangiopathies (CNR-MAT), Saint-Antoine University Hospital, AP-HP, Paris, France
10Sanofi, San Diego, CA
11Rare Blood Disorder Therapeutic Area, Sanofi, Cambridge, MA
12Sanofi, Sao Paulo, Brazil
13Sanofi, Cambridge, MA
14Cardiometabolic Programme, NIHR UCLH/UCL BRC, Department of Haematology, University College London Hospital, London, United Kingdom